PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer
Clinical trial NCT05880082 · COMPLETED
Trial details
- NCT number
- NCT05880082
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-13
- Primary completion
- 2025-08-18
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.